Full Press Release Details
| Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 | ||
| Tel | :+91 40 4900 2900 | |
| Fax | :+91 40 4900 2999 | |
| :mail@drreddys.com | ||
| www.drreddys.com |
Ref.: Scrip Code: 500124 (BSE), DRREDDY (NSE), RDY (NYSE)
Subject: Outcome of National Company Law Tribunal Convened Meetings of the Equity Shareholders and Unsecured Creditors of Dr. Reddy's Laboratories Limited (the "Company") and their voting results
Kindly refer to our letter dated November 30, 2019 in relation to the meetings of Equity Shareholders and Unsecured Creditors of the Company held on Thursday, January 2, 2020, at 11:00 A.M. & 3:00 P.M. respectively. Pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Order of the Hon'ble National Company Law Tribunal (NCLT), Hyderabad Bench at Hyderabad ("Tribunal") dated November 22, 2019, we submit the following:
We further wish to inform that, as per the Scrutinizers' reports the Equity Shareholders and Unsecured Creditors of the Company, at their respective meetings held on January 2, 2020 have approved the proposed Scheme of Amalgamation and Arrangement with the requisite majority.
The above documents will also be available on website of the Company at https://www.drreddys.com/investors/investor-services/amalgamation/.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
CC: New York Stock Exchange Inc. - Stock Code: RDY
National Securities Depositary Limited (NSDL)
Summary of the proceedings of the National Company Law Tribunal ("NCLT") Convened
Meeting of the Equity Shareholders of Dr. Reddy's Laboratories Limited ("Company") held
on Thursday, January 2, 2020 at 11.00 a.m. at The Ballroom, Hotel Park Hyatt, Road No. 2,
Banjara Hills, Hyderabad - 500034, Telangana, India
The meeting of the Equity Shareholders of Dr. Reddy's Laboratories Limited convened pursuant to the Order of the Hon'ble National Company Law Tribunal, Hyderabad Bench at Hyderabad ("Tribunal"), dated November 22, 2019, was held on Thursday, January 2, 2020 at 11.00 a.m. at The Ballroom, Hotel Park Hyatt, Road No. 2, Banjara Hills, Hyderabad - 500034, Telangana, India in the matter of Scheme of Amalgamation and Arrangement among Dr. Reddy's Holdings Limited ("Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Amalgamated Company") and their respective shareholders ("Scheme").
The following were in attendance:
Equity Shareholders present at the Meeting:
Mr. Amir Ali M. Bavani, who was appointed as the Chairperson of the Meeting pursuant to the Order of Hon'ble Tribunal dated November 22, 2019, took the chair. The requisite quorum being present, the Chairperson called Meeting to order.
The Register of Proxies, Statutory Registers and other documents as mentioned in the Notice dated November 26, 2019 were available for inspection by the Equity Shareholders at the Meeting.
The Chairperson informed that the Notice of the meeting, the Explanatory Statement under Sections 230(3), 232(1), 232(2) and 102 of the Companies Act, 2013 read with rules framed thereunder and the Scheme containing all the statutory annexures were dispatched to all the Equity Shareholders. With the consent of the Equity Shareholders, the Notice of the Meeting was taken as read.
Mr. Saumen Chakraborty, Chief Financial Officer of the Company, thereafter, provided brief background, rationale and salient features of the Scheme.
The following item of business as set out in the Notice convening the Meeting was put up to the Equity Shareholders for approval:
| Sr. No | Item of Business | Approval Required | ||
| 1. | Approval of the Scheme of Amalgamation and Arrangement between Dr. Reddy's Holdings Limited (Amalgamating Company) and Dr. Reddy's Laboratories Limited (Amalgamated Company) and their respective shareholders pursuant to the provisions of Sections 230-232 read with Section 66 and other relevant provisions of the Companies Act, 2013 | Requisite majority ( majority persons representing three-fourths in value as per Companies Act, 2013 and majority of Public Shareholders as per clause (I)(A)(9)(b) of Annexure-I of Securities and Exchange Board of India Circular dated March 10, 2017) |
The Chairperson informed the Equity Shareholders that as required under the Companies Act, 2013 read with Companies (Compromises, Arrangements and Amalgamations) Rules, 2016 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), the Company had provided its Equity Shareholders the facility to cast their vote through Postal Ballot and Remote e-voting system administered by the National Securities Depository Limited between Tuesday, December 3, 2019 at 9.00 A.M. (IST) till Wednesday, January 1, 2020 at 5.00 P.M. (IST).
Further, Mr. Sandeep Poddar, Company Secretary informed the Equity Shareholders that the facility of voting through Ballot / Polling Paper at the venue of the Meeting is also made available for the benefit of the Equity Shareholders who were present at the Meeting but could not cast their vote through Remote e-voting or Postal Ballot. He also informed that Ms. Ranjani Ramesh, Advocate was appointed as the Scrutinizer by the Hon'ble Tribunal vide its Order dated November 22, 2019 to scrutinize the votes cast at the Meeting and also the votes cast by way of Remote e-voting and Postal Ballot, in an independent and fair manner.
The Chairperson then invited the Equity Shareholders to express their views, ask questions and seek clarifications on the proposed Scheme. The Equity Shareholders expressed their satisfaction regarding the information provided in the notice dated November 26, 2019 and stated that they support the proposed resolution.
At request of the Chairperson, the Equity shareholders cast their votes on the resolution as mentioned in the Notice convening the Meeting, by Ballot / Polling Paper at the venue of the Meeting.
The Chairperson informed the Equity Shareholders that the combined results of the Postal Ballot, Remote e-voting and voting by Ballot / Polling Paper at the venue of the Meeting would be announced within 48 hours of the conclusion of the Meeting. The results along with the Scrutinizer's Report would be intimated to the Stock Exchanges in terms of the Listing Regulations, placed on the website of the Company as well as on the website of National Securities Depository Limited and would also be displayed at the Registered Office of the Company.
Subsequently, the Meeting was announced as closed.
Thereafter, the Scrutinizer's Report was received as per which, the Equity Shareholders have approved the proposed Scheme of Amalgamation and Arrangement with the requisite majority
This is for your information and records.
For Dr. Reddy's Laboratories Limited
| /s/ Sandeep Poddar | |
| Sandeep Poddar | |
| Company Secretary |
DR REDDY'S LABORATORIES LIMITED
NCLT convened Equity Shareholders meeting Voting Results Under Regulations 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Majority of persons representing three-fourth in value - including promoter and promoter group
Resolution 1: Approval of the proposed Scheme of Amalgamation and Arrangement among Dr. Reddy's Holdings Limited ("Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Amalgamated Company") and their respective shareholders.
| Date of NCLT convened meeting of equity shareholders: | January 2, 2020 | |
| Total No. of shareholders on record date (November 15, 2019): | 119,904 | |
| No. of Shareholders present in the meeting either in person or through proxy: | 137 | |
| Promoter and Promoter Group: | 8 | |
| Public: | 129 | |
| No. of Shareholders present in the meeting through video conferencing: Promoters and promoter Group: Public: | Not Applicable | |
| Resolution required: (Ordinary / Special) | Special Resolution | |
| Whether promoter/promoter group are interested in the agenda/resolution ? | Yes |
| Category | Mode of Voting | No. of shares held (1) | No. of votes polled (2) | % of Votes Polled on outstanding shares (3)=[(2)/(1)]*100 | No. of Votes - in favor (4) | No. of Votes - against (5) | % of Votes in favour on votes polled (6)=[(4)/(2)]*100 | % of Votes against on votes polled (7)=[(5)/(2)]*100 | |||||||||||||||||||||||
| Promoter & Promoter Group | Remote E-Voting | 44,458,528 | 100.00 | % | 44,458,528 | - | 100.00 | % | 0.00 | % | |||||||||||||||||||||
| Postal Ballot | - | 0.00 | % | - | - | 0.00 | % | 0.00 | % | ||||||||||||||||||||||
| Ballot / Polling Paper at the venue | - | 0.00 | % | - | - | 0.00 | % | 0.00 | % | ||||||||||||||||||||||
| Total | 44,458,528 | 44,458,528 | 100.00 | % | 44,458,528 | - | 100.00 | % | 0.00 | % | |||||||||||||||||||||
| Public- Institutions | Remote E-Voting | 85,945,638 | 80.21 | % | 85,934,372 | 11,266 | 99.99 | % | 0.01 | % | |||||||||||||||||||||
| Postal Ballot | 249,852 | 0.23 | % | 249,852 | - | 100.00 | % | 0.00 | % | ||||||||||||||||||||||
| Ballot / Polling Paper at the venue | - | 0.00 | % | - | - | 0.00 | % | 0.00 | % | ||||||||||||||||||||||
| Total | 107,152,220 | 86,195,490 | 80.44 | % | 86,184,224 | 11,266 | 99.99 | % | 0.01 | % | |||||||||||||||||||||
| Public- Non Institutions | Remote E-Voting | 212,414 | 1.46 | % | 210,871 | 1,543 | 99.27 | % | 0.73 | % | |||||||||||||||||||||
| Postal Ballot | 132,763 | 0.91 | % | 124,571 | 8,192 | 93.83 | % | 6.17 | % | ||||||||||||||||||||||
| Ballot / Polling Paper at the venue | 120,133 | 0.83 | % | 120,108 | 25 | 99.98 | % | 0.02 | % | ||||||||||||||||||||||
| Total | 14,535,000 | 465,310 | 3.20 | % | 455,550 | 9,760 | 97.90 | % | 2.10 | % | |||||||||||||||||||||
| TOTAL | 166,145,748 | 131,119,328 | 78.92 | % | 131,098,302 | 21,026 | 99.98 | % | 0.02 | % |
DR REDDY'S LABORATORIES LIMITED
NCLT convened Equity Shareholders meeting Voting Results Under Regulations 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Majority of public shareholders - excluding promoter and promoter group
Resolution 1: Approval of the proposed Scheme of Amalgamation and Arrangement among Dr. Reddy's Holdings Limited ("Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Amalgamated Company") and their respective shareholders.
| Date of NCLT convened meeting of equity shareholders: | January 2, 2020 | |
| Total No. of shareholders on record date (November 15, 2019): | 119,904 | |
| No. of Shareholders present in the meeting either in person or through proxy: | 137 | |
| Promoter and Promoter Group: | 8 | |
| Public: | 129 | |
| No. of Shareholders present in the meeting through video conferencing: Promoters and promoter Group: Public: | Not Applicable | |
| Resolution required: (Ordinary / Special) | Special Resolution* | |
| Whether promoter/promoter group are interested in the agenda/resolution ? | Yes |
| Category | Mode of Voting | No. of shares held (1) | No. of votes polled (2) | % of Votes Polled on outstanding shares (3)=[(2)/(1)]*100 | No. of Votes - in favor (4) | No. of Votes - against (5) | % of Votes in favour on votes polled (6)=[(4)/(2)]*100 | % of Votes against on votes polled (7)=[(5)/(2)]*100 | |||||||||||||||||||||||
| Promoter & Promoter Group | Remote E-Voting | - | - | - | - | - | - | ||||||||||||||||||||||||
| Postal Ballot | - | - | - | - | - | - | |||||||||||||||||||||||||
| Ballot / Polling Paper at the venue | - | - | - | - | - | - | |||||||||||||||||||||||||
| Total | 44,458,528 | - | - | - | - | - | - | ||||||||||||||||||||||||
| Public- Institutions | Remote E-Voting | 85,945,638 | 80.21 | % | 85,934,372 | 11,266 | 99.99 | % | 0.01 | % | |||||||||||||||||||||
| Postal Ballot | 249,852 | 0.23 | % | 249,852 | - | 100.00 | % | 0.00 | % | ||||||||||||||||||||||
| Ballot / Polling Paper at the venue | - | 0.00 | % | - | - | 0.00 | % | 0.00 | % | ||||||||||||||||||||||
| Total | 107,152,220 | 86,195,490 | 80.44 | % | 86,184,224 | 11,266 | 99.99 | % | 0.01 | % | |||||||||||||||||||||
| Public- Non Institutions | Remote E-Voting | 212,414 | 1.46 | % | 210,871 | 1,543 | 99.27 | % | 0.73 | % | |||||||||||||||||||||
| Postal Ballot | 132,763 | 0.91 | % | 124,571 | 8,192 | 93.83 | % | 6.17 | % | ||||||||||||||||||||||
| Ballot / Polling Paper at the venue | 120,133 | 0.83 | % | 120,108 | 25 | 99.98 | % | 0.02 | % | ||||||||||||||||||||||
| Total | 14,535,000 | 465,310 | 3.20 | % | 455,550 | 9,760 | 97.90 | % | 2.10 | % | |||||||||||||||||||||
| TOTAL | 166,145,748 | 86,660,800 | 52.16 | % | 86,639,774 | 21,026 | 99.98 | % | 0.02 | % |
* Since the scheme involves Dr. Reddy's Laboratories Limited (Listed company) and Dr. Reddy's Holdings Limited (promoter company), only the votes cast by the public shareholders are considered. Pursuant to requirements of SEBI Circular No. CFD/DIL3/CIR/2017/21 dated March 10, 2017, the votes cast in favor by such public shareholders are more than the votes cast against.
CONSOLIDATED SCRUTINIZER'S REPORT
Mr. Amir Ali M. Bavani, Advocate,
Chairperson Appointed by the Hon'ble National Company Law Tribunal ("NCLT"), Hyderabad Bench for the Meeting of the Equity Shareholders of Dr. Reddy's Laboratories Limited pursuant to Company Scheme Application CA (CAA) No. 231/230/HDB/2019.
Sub: Consolidated Scrutinizer's report with respect to voting by Equity Shareholders carried out through Postal Ballot, Remote e-voting and through Ballot / Polling Paper at the venue of the Meeting, for the Hon'ble NCLT convened meeting of the Equity Shareholders of Dr. Reddy's Laboratories Limited (the "Company")
I, Ms. Ranjani Ramesh, Advocate, have been appointed as the Scrutinizer by the Hon'ble National Company Law Tribunal, Hyderabad Bench at Hyderabad ("NCLT" or "Tribunal") vide order dated November 22, 2019 passed in Company Scheme Application CA (CAA) No. 231/230/HDB/2019 for the purpose of scrutinizing and ascertaining the results of voting carried out through Postal Ballot, Remote e - voting, and Ballot / Polling Paper at the venue of the Meeting of the Equity Shareholders (including Promoters and Promoter Group) of Dr. Reddy's Laboratories Limited held on January 2, 2020 at 11.00 A.M. at The Ballroom, Hotel Park Hyatt, Road No. 2, Banjara Hills, Hyderabad - 500034, Telangana, India seeking approval of the Equity Shareholders for the Scheme of Amalgamation and Arrangement among Dr. Reddy's Holdings Limited ("Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Amalgamated Company") and their respective shareholders in terms of the aforesaid order.
I do hereby report and submit as under:
A - VOTES IN FAVOUR OF THE RESOLUTION:
| Manner of Voting | Number of Equity Shareholders voted (in person or by proxy) | Number of votes cast by Equity Shareholders | % of total number of votes cast | |||||||||
| Remote e-voting | 1,124 | 13,06,03,771 | 99.61 | % | ||||||||
| Postal Ballot | 136 | 3,74,423 | 0.29 | % | ||||||||
| Ballot / Polling Paper | 92 | 1,20,108 | 0.09 | % | ||||||||
| Total | 1,352 | 13,10,98,302 | 99.98 | % |
B - VOTES AGAINST THE RESOLUTION:
| Manner of Voting | Number of Equity Shareholders voted (in person or by proxy) | Number of votes cast by Equity Shareholders | % of total number of votes cast | |||||||||
| Remote e-voting | 20 | 12,809 | 0.01 | % | ||||||||
| Postal Ballot | 2 | 8,192 | 0.01 | % | ||||||||
| Ballot / Polling Paper | 10 | 25 | 0.00 | % | ||||||||
| Total | 32 | 21,026 | 0.02 | % |
| Manner of Voting | Number of Equity Shareholders whose votes were declared invalid | Number of votes cast by them | ||||||
| Remote e-voting | - | - | ||||||
| Postal Ballot | 33 | 8,135 | ||||||
| Ballot / Polling Paper | 11 | 413 | ||||||
| Total | 44 | 8,548 |
Date: January 2, 2020
| Ms. Ranjani Ramesh | |
| Advocate | |
| (Scrutinizer for the meeting, appointed by NCLT) |
| Witness (1): | /s/ Josy Joseph | |
| Josy Joseph | ||
| 2-1-2020 | ||
| Witness (2): | /s/ Narender Reddy Nallamilli | |
| Narender Reddy Nallamilli | ||
| 2-1-2020 |
CONSOLIDATED SCRUTINIZER'S REPORT
Mr. Amir Ali M. Bavani,
Chairperson Appointed by the Hon'ble National Company Law Tribunal ("NCLT"), Hyderabad Bench for the Meeting of the Equity Shareholders of Dr. Reddy's Laboratories Limited pursuant to Company Scheme Application CA (CAA) No. 231/230/HDB/2019.
Sub: Consolidated Scrutinizer's report with respect to voting by Public Shareholders (excluding Promoters and Promoter Group) of Dr. Reddy's Laboratories Limited (the "Company") through Postal Ballot, Remote e-voting and through Ballot / Polling Paper at the venue of the Meeting in terms of SEBI Circular No. CFD/DIL3/CIR/2017/21 dated March 10, 2017
I, Ms. Ranjani Ramesh, have been appointed as the Scrutinizer by the Hon'ble National Company Law Tribunal, Hyderabad Bench at Hyderabad ("NCLT" or "Tribunal") vide order dated November 22, 2019 passed in Company Scheme Application CA (CAA) No. 231/230/HDB/2019 for the purpose of scrutinizing and ascertaining the results of voting carried out through Postal Ballot, Remote e-voting, and Ballot / Polling Paper at the venue of the Meeting of the Equity Shareholders (excluding Promoters and Promoter Group) of Dr. Reddy's Laboratories Limited held on January 2, 2020 at 11.00 A.M. at The Ballroom, Hotel Park Hyatt, Road No. 2, Banjara Hills, Hyderabad - 500034, Telangana, India seeking approval of the Equity Shareholders for the Scheme of Amalgamation and Arrangement among Dr. Reddy's Holdings Limited ("Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Amalgamated Company") and their respective shareholders in terms of the aforesaid order.
I do hereby report and submit as under:
A - VOTES IN FAVOUR OF THE RESOLUTION:
| Manner of Voting | Number of Equity Shareholders voted (in person or by proxy) | Number of votes cast by Equity Shareholders | % of total number of votes cast | |||||||||
| Remote e-voting | 1,113 | 8,61,45,243 | 99.41 | % | ||||||||
| Postal Ballot | 136 | 3,74,423 | 0.43 | % | ||||||||
| Ballot / Polling Paper | 92 | 1,20,108 | 0.14 | % | ||||||||
| Total | 1,341 | 8,66,39,774 | 99.98 | % |
B - VOTES AGAINST THE RESOLUTION:
| Manner of Voting | Number of Equity Shareholders voted (in person or by proxy) | Number of votes cast by Equity Shareholders | % of total number of votes cast | |||||||||
| Remote e-voting | 20 | 12,809 | 0.01 | % | ||||||||
| Postal Ballot | 2 | 8,192 | 0.01 | % | ||||||||
| Ballot / Polling Paper | 10 | 25 | 0.00 | % | ||||||||
| Total | 32 | 21,026 | 0.02 | % |
| Manner of Voting | Number of Equity Shareholders whose votes were declared invalid | Number of votes cast by them | ||||||
| Remote e-voting | - | - | ||||||
| Postal Ballot | 33 | 8,135 | ||||||
| Ballot / Polling Paper | 11 | 413 | ||||||
| Total | 44 | 8,548 |
Date: January 2, 2020
| 2/1/2020 | |
| Ms. Ranjani Ramesh | |
| Advocate | |
| (Scrutinizer for the meeting, appointed by NCLT) |
| Witness (1): | /s/ Josy Joseph | |
| Josy Joseph | ||
| 2-1-2020 | ||
| Witness (2): | /s/ Narender Reddy Nallamilli | |
| Narender Reddy Nallamilli | ||
| 2-1-2020 |
SCRUTINIZER'S REPORT
Mr. D. Narendar Naik,
Chairperson Appointed by the Hon'ble National Company Law Tribunal (NCLT), for the Meeting of the Unsecured Creditors of Dr. Reddy's Laboratories Limited pursuant to Company Scheme Application CA (CAA) no. 231/230/HDB/2019.
Sub: Scrutinizer's Report with respect to voting by unsecured creditors carried out through Ballot / Polling Paper at the venue of the Meeting, for the Hon'ble NCLT convened meeting of the Unsecured Creditors of Dr. Reddy's Laboratories Limited (the "Company")
I, Ms. K. Sree Ramya Munipalle, have been appointed as the Scrutinizer by the Hon'ble National Company Law Tribunal, Hyderabad Bench at Hyderabad ("NCLT" or "Tribunal") vide order dated November 22, 2019 passed in Company Scheme Application CA (CAA) No. 231/230/HDB/2019 for the purpose of scrutinizing and ascertaining the results through Ballot / Polling Paper at the venue of the Meeting of the Unsecured Creditors of Dr. Reddy's Laboratories Limited held on January 2, 2020 at 3.00 P.M. at The Ballroom, Hotel Park Hyatt, Road No. 2, Banjara Hills, Hyderabad - 500034, Telangana, India seeking approval of the Unsecured Creditors for the Scheme of Amalgamation and Arrangement among Dr. Reddy's Holdings Limited ("Amalgamating Company") and Dr. Reddy's Laboratories Limited ("Amalgamated Company") and their respective shareholders in terms of the aforesaid order.
I do hereby report and submit as under:
H.No 1-1-365A, Flat No 104 A Block, Siddam Setty Towers, Street No. 5, Jawahar Nagar, Near RTC X Roads
Hyderabad-500020 T S. Cell : 8096819955, Email ksreeramya10@gmail.com
H.No 1-1-365A, Flat No 104 A Block, Siddam Setty Towers, Street No. 5, Jawahar Nagar, Near RTC X Roads
Hyderabad-500020 T S. Cell : 8096819955, Email ksreeramya10@gmail.com
A - VOTES IN FAVOUR OF THE RESOLUTION:
| Manner of Voting | Number of Unsecured Creditors voted (in person or by proxy) | Number of votes cast by Unsecured Creditors | % of total number of votes cast | |||||||||
| Ballot / Polling Paper | 74 | 12,596,770,778 | 100.00 | % | ||||||||
| Total | 74 | 12,596,770,778 | 100.00 | % |
B - VOTES AGAINST THE RESOLUTION:
| Manner of Voting | Number of Unsecured Creditors voted (in person or by proxy) | Number of votes cast by Unsecured Creditors | % of total number of votes cast | |||||||||
| Ballot / Polling Paper | 0 | 0 | 0 | |||||||||
| Total | 0 | 0 | 0 |
| Manner of Voting | Number of Unsecured Creditors whose votes were declared invalid | Number of votes cast by them | ||||||
| Ballot / Polling Paper | 1 | 13,843,506 | ||||||
| Total | 1 | 13,843,506 |
H.No 1-1-365A, Flat No 104 A Block, Siddam Setty Towers, Street No. 5, Jawahar Nagar, Near RTC X Roads
Hyderabad-500020 T S. Cell : 8096819955, Email ksreeramya10@gmail.com
Date: January 2, 2020
Ms. K. Sree Ramya Munipalle
(Scrutinizer for the meeting, appointed by NCLT)
| Witness (1): | /s/ CA M V SESHA TALPA SAI | |
| CA M V SESHA TALPA SAI | ||
| Witness (2): | /s/ KUNAL SINGHANIYA | |
| (KUNAL SINGHANIYA) |
H.No 1-1-365A, Flat No 104 A Block, Siddam Setty Towers, Street No. 5, Jawahar Nagar, Near RTC X Roads
Hyderabad-500020 T S. Cell : 8096819955, Email ksreeramya10@gmail.com